Generics Successful at Invalidating Novartis Gilenya Patent April 12, 2017PatentAIA Trials, anticipation, IPR, motivation to combine, obviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post. Login